Conley Chee
Algemeen Directeur bij SYROS PHARMACEUTICALS, INC.
Vermogen: 114 770 $ op 31-05-2024
Profiel
Conley Chee is currently the President, Chief Executive Officer & Director at Syros Pharmaceuticals, Inc. Prior to this, he worked at Novartis Pharmaceuticals as the Global Head-Portfolio Management from 2018 to 2021.
Mr. Chee completed his undergraduate degree at the University of Alberta and holds an MBA from the Richard Ivey School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 05-04-2024 | 22 504 ( 0.08% ) | 114 770 $ | 31-05-2024 |
Actieve functies van Conley Chee
| Bedrijven | Functie | Begin |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Algemeen Directeur | 02-12-2023 |
Eerdere bekende functies van Conley Chee
| Bedrijven | Functie | Einde |
|---|---|---|
Novartis Pharmaceuticals
 Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The company is based in Basel, Germany. | Corporate Officer/Principal | 28-02-2021 |
Opleiding van Conley Chee
| Richard Ivey School of Business | Masters Business Admin |
| University of Alberta | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SYROS PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Novartis Pharmaceuticals
Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The company is based in Basel, Germany. | Health Technology |
